This invention provides modified release solid oral dosage form comprising a therapeutically effective amount of pridopidine base, and at least one pharmaceutically acceptable rate controlling excipient.
申请公布号
WO2017015615(A1)
申请公布日期
2017.01.26
申请号
WO2016US43696
申请日期
2016.07.22
申请人
TEVA PHARMACEUTICALS INTERNATIONAL GMBH;TEVA PHARMACEUTICALS USA, INC.;LICHT, Danit;LOVINGER, Ioana;SAFADI, Muhammed
